Scale Up Your In Vitro Services with Smarter Compound Uptake Screening in any type of cell
Offer your clients a smarter, real-time, high-throughput uptake screening solution compatible with antibiotic development
Fast
Time-efficient results for faster go/no-go decisions.
High Throughput
Screen thousands of compounds with standardised metrics.
Client-Ready Data
Provide quantitative metrics your clients can act on.
Versatile
Works in both human and bacterial cells, ideal for antimicrobial research.
About Us
Smarter ADME Screening for CROs
Drug innovation, specifically antimicrobial development, is held back by inefficient tools for studying compound uptake and permeation.
At DrugUptech, our high-throughput uptake screening platform equips CROs with faster, real time studies in any cell type or bacteria – especially for pharmaceutical clients developing antimicrobials.
Expand their service offering
Cut down assay time and variability
Provide clients with real-time, quantitative data on compound uptake and permeability in a wide range of cell types
Our Technology
Real-Time, Plate-Based Assays for Compound Uptake
Whether you’re supporting pharma, antimicrobial research, or AgriTech clients, our platform gives you the power to screen compound uptake and permeation quickly and consistently – across plant, bacterial, or mammalian cell types.
No specialist mass spectrometry required – just a plate reader and our proprietary assay format
Benefits include:
Quantitative comparison of compound uptake
Compatibility with high-throughput workflows
Broad cell-type support (bacteria, plant, human)
Reproducible, standardised output for client reports
Opportunity to offer novel data insights in antimicrobial, drug delivery, or crop testing pipelines
We are working with early CRO partners to develop validated case studies.
Expand Your Screening Offering
Offer compound uptake and permeability assays as a new service for clients in pharma, biotech, or AgriTech.
Generate Quantitative, Actionable Data
Help clients make faster formulation and development decisions using standardised, real-time uptake and permeability metrics.
Antimicrobial Research
Our platform enables the study of uptake and efflux kinetics of antimicrobials in bacteria.
Get In Touch
Join our early partner programme and bring new value to your clients with real-time uptake analysis.
Email us at:
j.l.ortega-roldan@kent.ac.uk